HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masaharu Hanai Selected Research

apricoxib

3/2008CS-706, a novel cyclooxygenase-2 selective inhibitor, prolonged the survival of tumor-bearing mice when treated alone or in combination with anti-tumor chemotherapeutic agents.
6/2007Therapeutic effect of CS-706, a specific cyclooxygenase-2 inhibitor, on gallbladder carcinoma in BK5.ErbB-2 mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masaharu Hanai Research Topics

Disease

2Neoplasms (Cancer)
03/2008 - 06/2007
1Liver Neoplasms (Liver Cancer)
10/2019
1Colonic Neoplasms (Colon Cancer)
03/2008
1Carcinoma (Carcinomatosis)
06/2007
1Biliary Tract Neoplasms (Biliary Tract Cancer)
06/2007
1Gallbladder Neoplasms (Gallbladder Cancer)
06/2007

Drug/Important Bio-Agent (IBA)

2apricoxibIBA
03/2008 - 06/2007
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2008 - 06/2007
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
03/2008 - 06/2007
1Biomarkers (Surrogate Marker)IBA
10/2019
1Cisplatin (Platino)FDA LinkGeneric
03/2008
1Celecoxib (Celebrex)FDA Link
03/2008
1Therapeutic UsesIBA
06/2007
1ErbB Receptors (EGF Receptor)IBA
06/2007
1Proteins (Proteins, Gene)FDA Link
06/2007
1Messenger RNA (mRNA)IBA
06/2007

Therapy/Procedure

1Oral Administration
03/2008
1Therapeutics
06/2007